期刊文献+

食管癌患者IGF-1 CEA水平检测的临床意义 被引量:3

Clinical significance of IGF-1 and CEA in esophageal cancer patients
原文传递
导出
摘要 目的检测食管癌患者血清胰岛素样生长因子-1(IGF-1)及癌胚抗原(CEA)的浓度并探讨其临床意义。方法应用化学发光法检测54例食管癌患者和22例正常人的血清IGF-1及CEA的浓度。结果正常健康人血清IGF-1的含量为(196.75±58.31)ng/ml,血清CEA值为(5.4±1.9)ng/ml,而食管癌患者血清IGF-1含量为(1092.59±311.44)ng/m l,血清CEA值为CEA为(30.2±14.1)ng/ml。食管癌患者组明显高于正常对照组(P<0.01),且血清IGF-1水平及CEA值随临床病理分期的进展而逐步增高(P<0.05)。结论血清中高水平的IGF-1和CEA可能成为食管癌的一个报警信号,在一定程度上反映食管癌的病情进展,有利于治疗措施的选择和预后的判断。 Objective To detection the serum insulin-like growth factor-1(IGF-1)level and carcinoembryonic antigen(CEA) in patients with esophageal cancer and investigate its clinical significance.Methods The serum IGF-1 level and CEA is determined by chemiluminescence assay in 55 esophageal cancer patients,22 normal subjects are taken as control group.Results The IGF-1 level of nomal control group is(196.75±58.31)ng/ml,The CEA level of nomal control group is(5.4±1.9) ng/ml.the IGF-1 and CEA of patients are(1092.59±311.44)ng/ml and 30.2±14.1 ng/ml,which are higher than that of the control(P〈0.01).The level of IGF-1 and CEA also elevate as the clinical pathological tumor stages(P〈0.05).Conclusions The hight level of serum IGF-1 and CEA will be a warning signal of esophageal cancer.They can profit the choice of the therapeutic measure and judgement of the prognosis.
作者 刘天舟 马忘
出处 《医药论坛杂志》 2011年第6期54-56,共3页 Journal of Medical Forum
关键词 IGF-1 CEA 食管癌 肿瘤标志物 血清 IGF - 1 CEA Esophageal cancer Tumor marker Serum
  • 相关文献

参考文献4

二级参考文献37

  • 1罗朝学,程绍钧,李前伟.HepG_2人肝癌细胞胰岛素样生长因子1受体定量分析[J].第三军医大学学报,2005,27(3):206-208. 被引量:5
  • 2Ychou M, Khemissa-Akouz F, Kramar A, et al. A comparison of serum Cyfra 21-1 and SCC AG in the diagnosis of squamous cell esophageal carcinoma. Bull Cancer, 2001, 88:1023-1027. 被引量:1
  • 3Kawaguchi H, Ohno S, Miyazaki M, et al. CYFRA 21-1 detemdnation in patients with esophageal squamous cell carcinoma: clinical utility for detection of recurrences. Cancer, 2000, 89:1413-1417. 被引量:1
  • 4Petricoin EF, Ardekani AM, Hitt BA, et al. Use of proteomic patterns in serum to identify ovarian cancer, Lancet, 2002,359:572-577. 被引量:1
  • 5Zhou G, Li H, Decamp D, et al. 2D differential in-gel electrophoresis for the identification of esophageal cans cell cancer-specific protein markers. Mol Cell Proteomics, 2002, 1:117-124. 被引量:1
  • 6van Dalen A. Quality control and standardization of tumor marker tests. Tumor Biol, 1993,14:131-135. 被引量:1
  • 7Seynhaeve AL, de Wilh JH, van Tiel ST, et al. Isolated limb perfusion with actinomycin D and TNF - alpha results in improved tumor response in soft tissue sarcoma - bearing rats but is accompanied by sever local toxicity. Bj Cancer. 2002, 86:1174. 被引量:1
  • 8Lans TE, ten Hagen TL, van Horssen R, et al. Improved antitumor response to isolated limb perfusion with tumor necrosis factor after upregulation of endothelial monocyte - activating polypeptide Ⅱ in soft tissue sarcoma. Ann Surg Oncol. 2002, 9:812. 被引量:1
  • 9Tsimberidou AM, Giles FJ. TNF - alpha targeted therapeutic approaches in patients with hematologic malignancies. Exper Rev Anticancer Ther. 2002, 2:277. 被引量:1
  • 10De Wilt JH, Ten Hagen TL, de Boeck G, et al. Tumour necrosis factor - alpha increases melphalan concentration in tumor tissue after isolated limb perfusion. Br J Cancer. 2000, 82:1000. 被引量:1

共引文献51

同被引文献22

引证文献3

二级引证文献1

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部